When an athlete deadlifts over 900 lbs and breaks multiple world records, questions about performance-enhancing drugs are inevitable. Powerlifting phenom Larry Wheels has never been one to dodge the conversation. From heavy blasts of testosterone and Anadrol starting at age 17 to his dramatic shift toward health and TRT, Wheels has documented the highs and lows of chemical enhancement for the world to see.

In the high-stakes world of elite powerlifting, transparency is rare. Many athletes operate under a veil of secrecy regarding their protocols, fearing lost sponsorships or public backlash. Larry Wheels, however, has consistently provided a factual perspective on his own usage, detailing the clinical timelines of his cycles, the physical toll they took, and his ultimate realization that extreme performance often comes at a severe biological cost. This article meticulously breaks down his admitted substance use history, his physiological transition to a therapeutic testosterone baseline, and the medical implications of his journey.

The Early Years: When Did Larry Wheels Start Using Steroids?

Starting PEDs at Age 17

The timeline of Larry Wheels’ exposure to anabolic-androgenic steroids (AAS) began much earlier than most. Frustrated by the limits of his natural progression and driven by an intense desire to be the strongest man in the world, he initiated his first cycle at just 17 years old. From a medical standpoint, introducing exogenous androgens during adolescence is highly precarious, as it risks premature epiphyseal plate closure (stunting growth) and long-term disruption of the hypothalamic-pituitary-gonadal (HPG) axis. Despite these clinical risks, Wheels pursued enhancement aggressively. His early stacks were rudimentary but highly effective, dramatically accelerating his muscular hypertrophy and central nervous system (CNS) force output.

Breaking Personal Bests and World Records

By his early twenties, Wheels was setting records that defied conventional biomechanical expectations. He totaled over 2,275 lbs across the squat, bench press, and deadlift in competition. His rapid ascent was fueled by a combination of elite genetic response, ferocious training intensity, and continuous exposure to anabolic agents. During this era, his body mass expanded dramatically, and his connective tissues adapted to bear extreme mechanical loads. Yet, this superhuman output required escalating pharmacological support. He was not simply dabbling; he was pushing the absolute limits of human physiology, requiring continuous hormonal saturation to recover from multi-hour, max-effort training sessions.

Larry Wheels’ ‘Bread and Butter’ Steroid Stack

High-Dose Testosterone (Up to 1,200mg+)

In various candid interviews, Wheels has outlined the foundation of his peak powerlifting cycles. The cornerstone was exogenous testosterone. While a standard clinical TRT dose ranges from 100mg to 200mg per week, Wheels admitted to utilizing up to 1,200mg per week. At these supraphysiological dosages, testosterone induces profound protein synthesis and nitrogen retention. However, it also significantly increases the risk of polycythemia (elevated red blood cell count) and left ventricular hypertrophy. Such massive doses required constant monitoring to manage estrogenic conversion via aromatization, often necessitating the concurrent use of aromatase inhibitors.

Anadrol and Superdrol for Peak Strength

To maximize raw torque and acute strength leading into powerlifting meets, Wheels leaned heavily on oral androgens—most notably Anadrol (Oxymetholone) and Superdrol (Methasterone). Anadrol is notorious in clinical circles for its profound impact on erythropoiesis (red blood cell production) and its sheer strength-promoting capabilities. Dosages of 100mg to 150mg per day were utilized in his final peaking phases. While effective for breaking through strength plateaus, these C17-alpha alkylated compounds exert immense hepatotoxic stress on the liver and severely distort lipid profiles, crashing high-density lipoprotein (HDL) while elevating low-density lipoprotein (LDL).

Trenbolone and Dianabol Experiments

Wheels has also spoken about experimenting with other potent compounds like Trenbolone and Dianabol. Trenbolone, a 19-nortestosterone derivative originally designed for veterinary use, is highly valued for its nutrient-partitioning effects and its lack of estrogenic conversion. However, Wheels eventually minimized its use due to the harsh psychological side effects and severe cardiovascular strain it induced. Dianabol, a classic mass-builder, was utilized for rapid glycogen retention and intra-muscular fluid accumulation, which provided the necessary leverage for heavy presses and squats.

The Health Toll: Why Larry Quit Full Steroid Cycles

The Deadlift Injury and ‘Wake-Up Call’

The inflection point in Larry Wheels’ journey occurred in mid-2022. While preparing for a major heavy lifting milestone, he sustained a severe back injury during a massive deadlift. This mechanical failure served as a stark “wake-up call.” For years, his muscular strength had outpaced the structural integrity of his connective tissues and skeletal framework. The injury forced a mandatory period of rest, providing him the mental space to evaluate the trajectory of his health. He realized that continuing to add weight to the bar would inevitably lead to catastrophic, potentially irreversible injuries.

Rhabdomyolysis and Cardiovascular Testing

Beyond structural injuries, the systemic toll of extreme performance enhancement was mounting. Wheels has discussed concerns regarding rhabdomyolysis—a serious syndrome resulting from skeletal muscle breakdown, where muscle fibers release their contents (myoglobin) into the bloodstream, threatening kidney function. Furthermore, the sheer mass and drug dosages raised significant red flags for heart health. A deep dive into the Cardiovascular Risks of Testosterone Replacement Therapy and extreme steroid use reveals elevated risks for arrhythmias, myocardial infarctions, and vascular calcification. Understanding heart disease risk factors, Wheels sought comprehensive cardiovascular testing, including echocardiograms, to assess the damage incurred by nearly a decade of heavy androgens.

The Transition to TRT (Testosterone Replacement Therapy)

Natural Testosterone Suppression

Having utilized high doses of exogenous androgens since his late teens, Wheels’ HPG axis was effectively dormant. The continuous influx of synthetic hormones signals the hypothalamus and pituitary gland to cease production of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). Consequently, his testes stopped producing endogenous testosterone. When deciding to stop his massive cycles, going completely “natural” was not a medically viable option. He would have faced profound, perhaps permanent, hypogonadism, resulting in severe depression, muscle wasting, bone density loss, and lethargy. The only rational clinical path was to establish a medically supervised baseline.

His Current 175mg/Week TRT Protocol

Today, Larry Wheels operates on a physician-monitored TRT protocol. He has transparently shared that his dosage is approximately 175mg of testosterone per week. This dosage is designed to keep his serum testosterone levels at the high end of the physiological reference range (typically 800-1000 ng/dL). As noted by various medical institutions discussing the benefits and risks of testosterone therapy, a carefully managed TRT protocol can restore metabolic health, stabilize mood, and preserve lean tissue without the exaggerated cardiovascular strain of a bodybuilder’s “blast.” Recent large-scale clinical trials, such as the Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE Trial), have reinforced that therapeutic testosterone—when kept within physiological parameters—does not inherently increase the incidence of major adverse cardiovascular events. The NIH confirms that clinical TRT does not increase heart risk for appropriately diagnosed hypogonadal men.

Relapse and the Bodybuilding ‘Mistake’

The Temptation of Classic Physique

Despite his commitment to health, the allure of the competitive stage proved tempting. In 2023, Wheels decided to pivot from powerlifting to competitive bodybuilding, aiming for the Classic Physique division. To attain the necessary conditioning and dry, striated look required for the stage, he briefly escalated his pharmacology back into bodybuilding “prep” territory. This involved reintroducing compounds meant to strip water and preserve muscle mass in a deep caloric deficit.

Re-committing to Long-Term Health and Longevity

Following the show, Wheels displayed his trademark honesty. He publicly stated that the bodybuilding prep was a “mistake” and acknowledged that relapsing into heavy PED use contradicted his health goals. The extreme restriction and chemical demands of contest prep severely impacted his well-being. He quickly ceased the advanced cycle, returning to his baseline 175mg TRT protocol, and reaffirmed his dedication to longevity over transient aesthetic trophies.

The Reality of Steroids in Powerlifting

Extreme Dosages vs. Genetic Potential

Larry Wheels’ journey underscores a critical truth about elite strength sports: chemical enhancement is prevalent, but it is merely an amplifier of extreme genetic potential. Even if an average individual replicated Wheels’ peak 1,200mg testosterone and 150mg Anadrol stack perfectly, they would not deadlift 900 lbs. His skeletal structure, fast-twitch muscle fiber density, and neurological efficiency are statistical anomalies. Steroids facilitated his recovery and accelerated his hypertrophy, but they did not create his foundational capability.

Why Transparency Matters for the Next Generation

In an industry often clouded by false natural claims and deceptive marketing, Larry Wheels stands out for his factual documentation. By revealing the exact dosages, the ensuing side effects, and his medical transition to TRT, he provides a cautionary yet educational blueprint. He has dispelled the myth of consequence-free steroid use, demonstrating that even world champions must eventually answer to clinical reality and prioritize their cardiovascular health.